Chai Discovery
Health
· Headquartered in United States 🇺🇸
Track Chai Discovery
— get Health deals in free daily digest
Overview
Chai Discovery, a San Francisco-based AI company, has raised $130 million in a Series B financing round co-led by Oak HC/FT and General Catalyst, achieving a valuation of $1.3 billion. The funding aims to advance AI-driven molecular design, addressing the challenge of predicting and reprogramming biochemical molecule interactions.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Oak HC/FT, General Catalyst
Chai Discovery, a San Francisco-based AI company, has raised $130 million in a Series B financing round co-led by Oak HC/FT and General Catalyst, achieving a valuation of $1.3 billion. The funding aims to advance AI-driven molecular design, addressing the challenge of predicting and reprogramming biochemical molecule interactions.
Investors: Oak HC/FT, General Catalyst
Chai Discovery, a San Francisco-based biotech, secured $130 million at a $1.3 billion valuation to develop a computer-aided design suite for molecules. Key investors include Oak HC/FT and General Catalyst. The funding aims to enhance drug discovery efficiency, targeting complex diseases.
More Health Deals
Market Map
View thousands of companies by category in our market map:
